Foscarnet sodium - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for foscarnet sodium and what is the scope of freedom to operate?

Foscarnet sodium is the generic ingredient in two branded drugs marketed by Amneal, Avet Lifesciences, Beijing, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, and Clinigen Hlthcare, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for foscarnet sodium. Eight suppliers are listed for this compound.

Summary for foscarnet sodium

US Patents:	0
Tradenames:	2
Applicants:	7
NDAs:	7
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	8
Raw Ingredient (Bulk) Api Vendors:	69
Clinical Trials:	24
Patent Applications:	6
What excipients (inactive ingredients) are in foscarnet sodium?	foscarnet sodium excipients list
DailyMed Link:	foscarnet sodium at DailyMed

Recent Clinical Trials for foscarnet sodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cttq	Phase 4
Peking University People's Hospital	Phase 4
National Cancer Institute (NCI)

See all foscarnet sodium clinical trials

Pharmacology for foscarnet sodium

Drug Class	Pyrophosphate Analog DNA Polymerase Inhibitor
Mechanism of Action	Chelating Activity DNA Polymerase Inhibitors

Medical Subject Heading (MeSH) Categories for foscarnet sodium

Antiviral Agents
Reverse Transcriptase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for foscarnet sodium

J05AD	Phosphonic acid derivatives
J05A	DIRECT ACTING ANTIVIRALS
J05	ANTIVIRALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for foscarnet sodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	FOSCARNET SODIUM	foscarnet sodium	INJECTABLE;INJECTION	212483-001	Jan 29, 2021	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	FOSCARNET SODIUM	foscarnet sodium	INJECTABLE;INJECTION	077174-001	May 31, 2005		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Avet Lifesciences	FOSCARNET SODIUM	foscarnet sodium	INJECTABLE;INJECTION	213807-001	Jun 5, 2023	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for foscarnet sodium

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.